These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20305394)

  • 1. Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters.
    Xue WF; Hellewell AL; Hewitt EW; Radford SE
    Prion; 2010; 4(1):20-5. PubMed ID: 20305394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibril fragmentation enhances amyloid cytotoxicity.
    Xue WF; Hellewell AL; Gosal WS; Homans SW; Hewitt EW; Radford SE
    J Biol Chem; 2009 Dec; 284(49):34272-82. PubMed ID: 19808677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid fibril length distribution quantified by atomic force microscopy single-particle image analysis.
    Xue WF; Homans SW; Radford SE
    Protein Eng Des Sel; 2009 Aug; 22(8):489-96. PubMed ID: 19581337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An imaging and systems modeling approach to fibril breakage enables prediction of amyloid behavior.
    Xue WF; Radford SE
    Biophys J; 2013 Dec; 105(12):2811-9. PubMed ID: 24359753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.
    Marin-Argany M; Lin Y; Misra P; Williams A; Wall JS; Howell KG; Elsbernd LR; McClure M; Ramirez-Alvarado M
    J Biol Chem; 2016 Sep; 291(38):19813-25. PubMed ID: 27462073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial extent of charge repulsion regulates assembly pathways for lysozyme amyloid fibrils.
    Hill SE; Miti T; Richmond T; Muschol M
    PLoS One; 2011 Apr; 6(4):e18171. PubMed ID: 21483680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.
    Liberta F; Loerch S; Rennegarbe M; Schierhorn A; Westermark P; Westermark GT; Hazenberg BPC; Grigorieff N; Fändrich M; Schmidt M
    Nat Commun; 2019 Mar; 10(1):1104. PubMed ID: 30846696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism of amyloid formation by Ab peptide: review of own works].
    Selivanova OM; Rogachevsky VV; Syrin AK; Galzitskaya OV
    Biomed Khim; 2018 Jan; 64(1):94-109. PubMed ID: 29460839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool.
    Gazit E
    FEBS J; 2005 Dec; 272(23):5971-8. PubMed ID: 16302962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology.
    Marek P; Abedini A; Song B; Kanungo M; Johnson ME; Gupta R; Zaman W; Wong SS; Raleigh DP
    Biochemistry; 2007 Mar; 46(11):3255-61. PubMed ID: 17311418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid fibril cytotoxicity and associated disorders.
    Saremi S; Khajeh K
    Prog Mol Biol Transl Sci; 2024; 206():265-290. PubMed ID: 38811083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia.
    Srinivasan R; Jones EM; Liu K; Ghiso J; Marchant RE; Zagorski MG
    J Mol Biol; 2003 Nov; 333(5):1003-23. PubMed ID: 14583196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and nanomechanical comparison of epitaxially and solution-grown amyloid β25-35 fibrils.
    Murvai Ü; Somkuti J; Smeller L; Penke B; Kellermayer MS
    Biochim Biophys Acta; 2015 May; 1854(5):327-32. PubMed ID: 25600136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Diversity of Amyloid Fibrils and Advances in Their Structure Determination.
    Li D; Liu C
    Biochemistry; 2020 Feb; 59(5):639-646. PubMed ID: 31967790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturation-dependent changes in the size, structure and seeding capacity of Aβ42 amyloid fibrils.
    Miller A; Chia S; Klimont E; Knowles TPJ; Vendruscolo M; Ruggeri FS
    Commun Biol; 2024 Feb; 7(1):153. PubMed ID: 38321144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.